NEW YORK (GenomeWeb News) – The Personalized Medicine Coalition today released a white paper outlining areas requiring more clarity from the US Food and Drug Administration on facilitating the development and regulatory review of drugs and companion tests to determine dosing, predict benefit, or gauge adverse reactions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.